Alzheimer’s disease is the most commonly diagnosed form of dementia, but it’s far from the only one. In fact, most people who ...
Late-breaking oral presentation by a leading global authority in Dementia with Lewy bodies (DLB) to highlight updated data from Phase 2b study on neflamapimod treatment for DLB. N ...
Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements include but are not limited to statements regarding the timing of future ...
Significant reduction in key neurodegeneration biomarker correlated with treatment response, suggesting neflamapimod may act on underlying disease CervoMed preparing to initiate Phase 3 registrational ...
Hallucinations refer to the experience of sensing things that seem real but do not exist. During a hallucination, you may see, hear, feel, smell, or taste things that are not there—meaning they have ...
Cognition is advancing CT1812 in the Phase 2 ‘SHIMMER’ clinical trial for the treatment of dementia with Lewy bodies with data readout in the fourth quarter of 2024 PURCHASE, N.Y., Oct. 01, 2024 ...
Dementia, affecting millions worldwide, isn’t a single condition but rather an umbrella term encompassing various disorders that impair cognitive function, memory, and everyday capabilities. Each type ...
Dr Kellyn Lee has highlighted sundowning, a lesser-known sign of dementia that often becomes more noticeable in the afternoon ...
A common symptom among people with dementia is agitation, which can affect their and their carers’ well-being. Dementia experts conducted a new study and found the most effective means of addressing ...
When we think about dementia, we often think of a person experiencing memory loss and confusion. While it’s true that these are certainly symptoms of dementia and Alzheimer’s (the most common form of ...
Dr Kellyn Lee has explained a lesser-known sign of dementia and how it can affect people living with the condition ...
Early detection is widely regarded as a fundamental step in managing Alzheimer's in the current world. The 2024 Lancet ...